1. Home
  2. BLZE vs VNDA Comparison

BLZE vs VNDA Comparison

Compare BLZE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$4.76

Market Cap

282.6M

Sector

Technology

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.25

Market Cap

425.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
VNDA
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.6M
425.5M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
BLZE
VNDA
Price
$4.76
$8.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
4
Target Price
$9.50
$13.13
AVG Volume (30 Days)
775.4K
2.8M
Earning Date
02-24-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$141,859,000.00
$212,074,000.00
Revenue This Year
$16.40
$12.01
Revenue Next Year
$11.07
$21.57
P/E Ratio
N/A
N/A
Revenue Growth
15.73
11.12
52 Week Low
$3.94
$3.81
52 Week High
$10.86
$9.60

Technical Indicators

Market Signals
Indicator
BLZE
VNDA
Relative Strength Index (RSI) 40.65 68.93
Support Level $4.63 $6.87
Resistance Level $4.92 $9.60
Average True Range (ATR) 0.18 0.49
MACD 0.10 0.13
Stochastic Oscillator 58.88 60.87

Price Performance

Historical Comparison
BLZE
VNDA

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: